To further confirm that promoting effect of BKM120 on apoptosis is specifically mediated by PI3K/AKT inhibition, chemoresistant breast cancer cells were treated with LY294002, another well-characterized selective PI3K/Akt inhibitor. Here, AKT1 is linked to breast cancer.